Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

p Comprehensive analyses of DNA methylation of the TIMP3 promoter in placentas from early-onset and late-onset preeclampsia

Full text
Author(s):
Cruz, Juliana de O. [1] ; Conceicao, Izabela M. C. A. [2] ; Sandrim, Valeria C. [3] ; Luizon, Marcelo R. [4, 1]
Total Authors: 4
Affiliation:
[1] Univ Fed Minas Gerais, Inst Biol Sci, Genet Grad Program, BR-31270901 Belo Horizonte, MG - Brazil
[2] Univ Fed Minas Gerais, Inst Biol Sci, Biochem & Immunol Grad Program, BR-31270901 Belo Horizonte, MG - Brazil
[3] Univ Estadual Paulista, Inst Biosci, Dept Biophys & Pharmacol, BR-18680000 Botucatu, SP - Brazil
[4] Univ Fed Minas Gerais, Inst Biol Sci, Dept Genet Ecol & Evolut, BR-31270901 Belo Horizonte, MG - Brazil
Total Affiliations: 4
Document type: Journal article
Source: Placenta; v. 117, p. 118-121, JAN 2022.
Web of Science Citations: 0
Abstract

Preeclampsia (PE) is classified into late-onset (LOPE) or early-onset (EOPE) according to gestational age of onset (>34 or <34 weeks, respectively), and into preterm and term (delivery at <37 or >37 weeks, respectively). An imbalanced expression of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) impairs proper placentation in PE, and DNA methylation (DNAm) may affect their expression. We performed comprehensive analyses of DNAm and TIMP3 expression in placentas from PE reclassified into EOPE, LOPE, and term PE. We identified significant differentially methylated probes at the TIMP3 promoter in PE (28), EOPE (38), LOPE (20), and term PE (4) compared to controls, and in EOPE vs. LOPE (8). Moreover, we found a hypomethylation >70% in all groups (except EOPE vs. LOPE) and an increased TIMP3 expression in corresponding placental samples from PE, EOPE and LOPE compared to controls (p<0.05). Our findings highlight the role of DNAm of the TIMP3 promoter region regarding an epigenetic mechanism in PE. (AU)

FAPESP's process: 19/07230-8 - Arginase in preeclampsia: study of genetic polymorphism, circulating factors and in vitro assays
Grantee:Valeria Cristina Sandrim
Support Opportunities: Regular Research Grants